## NDSN: Nordson Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 1.5% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($230.02)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. What Nordson (NDSN)'s Margin-Resilient Q4 Beat and 2026 Outlook Means For Shareholders**
- Source: Simply Wall Street | 20251218T125136 | Somewhat-Bullish | Relevance: 100%
- Nordson Corporation (NDSN) reported a strong Q4 2025 beat with sales of US$751.82 million and net income of US$151.63 million, alongside full-year sales of US$2.79 billion and net income of US$484.47 million. The company's adjusted earnings exceeded expectations, and its fiscal 2026 guidance projects sales of US$2.83–2.95 billion, indicating management's confidence in profitability despite limited organic growth. This performance underscores Nordson's margin resilience as a key driver for its investment narrative.

**2. NORDSON CORP SEC 10-K Report**
- Source: TradingView — Track All Markets | 20251217T214733 | Bullish | Relevance: 100%
- Nordson Corporation has released its 2025 Form 10-K report, highlighting significant financial growth, strategic initiatives, and operational success. The company reported robust financial performance with increased sales, operating profit, net income, and diluted EPS, driven by its Advanced Technology Solutions segment and strategic acquisitions. Nordson also outlined its Ascend strategy for long-term growth and discussed various challenges and risks, including economic conditions, trade policy, and supply chain disruptions.

**3. Nordson Corp. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20251217T171300 | Bullish | Relevance: 100%
- Nordson Corp. (NDSN) saw its stock advance 1.07% to $238.07 on Wednesday, outperforming the broader market which experienced a dismal trading session with the S&P 500 and Dow Jones Industrial Average falling. The company's stock closed 5.33% below its 52-week high reached on December 11th.

**4. Nordson Q3 2025 Earnings: Record Margin Expansion Offsets Flat Revenue - News and Statistics**
- Source: IndexBox | 20251217T090805 | Somewhat-Bullish | Relevance: 100%
- Nordson reported flat sales in Q3 2025 year-over-year but achieved a record EBITDA margin of 34% due to strong operational execution and portfolio optimization, including a divestiture. CEO Sundaram Nagarajan highlighted broad-based demand in medical products and stable aftermarket parts, which helped offset declines in polymer processing and x-ray systems. Despite revenue missing analyst estimates, adjusted EPS and EBITDA beat expectations, and the company provided guidance for Q4 2025 and the upcoming financial year 2026.

**5. Taking Stock of Nordson (NDSN) Valuation After Strong Q4 Beat and Upgraded 2026 Guidance**
- Source: Simply Wall Street | 20251217T082841 | Bullish | Relevance: 100%
- Nordson (NDSN) exceeded Q4 expectations for fiscal 2025 and provided optimistic 2026 guidance, reinforcing a "mid teens" year-to-date share price return. Despite trading at a premium compared to the US Machinery group, a narrative-based fair value suggests the stock is 10.5% undervalued, driven by strategic shifts towards recurring revenue and portfolio optimization. Investors are encouraged to explore a detailed analysis for a comprehensive understanding of its valuation and risks.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | DA Davidson | $290 | $285 | +2% |
| 2025-12-12 | Baird | $275 | $252 | +9% |
| 2025-12-11 | DA Davidson | $285 | $285 | 0% |
| 2025-12-11 | Keybanc | $295 | $250 | +18% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | DA Davidson | main | Buy |
| 2025-12-12 | Baird | main | Neutral |
| 2025-12-11 | DA Davidson | main | Buy |
| 2025-12-11 | Keybanc | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($1.77M) |
| Sells | 12 ($3.60M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 10.8% (-2.1%)
- Blackrock Inc.: 6.8% (-0.3%)
- State Street Corpora: 5.1% (-3.2%)
- Kayne Anderson Rudni: 4.4% (-2.4%)
- Geode Capital Manage: 2.7% (+1.3%)

### Key Risks

1. Insider selling cluster: $3.6M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +10%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Forward P/E 20.0x stretched relative to 8% growth. Quality metrics strong (margin 17%). Analyst sentiment positive (3 raises, avg +10%). Insider selling cluster ($3.6M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.4B |
| Beta | 1.02 |
| 52W Range | $165.03 - $251.47 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 20.0 |
| Current P/E | 21.5 |
| YoY Growth | 7.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at 1.5% (minimal 5-day change). Below STRENGTH zone by 2.5pp (needs >4.0% for momentum thesis). MRS_5 (-0.1%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). Elevated volume (1.9x 20MA), institutional activity likely. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.54% (CS: 66) | Neutral |
| RSI_14 | 60.3 | Neutral |
| MACD Histogram | 0.25 | Bullish |
| vs SMA20 | 1.016x | Above |
| vs SMA50 | 1.026x | Above |
| vs SMA200 | 1.110x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $240.38
- **Stop Loss:** $230.02 (4.3% risk)
- **Target:** $250.74 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 86
- **Position Value:** $20,672.68
- **Portfolio %:** 20.67%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $2.93 | $3.03 | +3.4% |
| 2025Q3 | $2.64 | $2.73 | +3.5% |
| 2025Q2 | $2.36 | $2.42 | +2.6% |
| 2025Q1 | $2.08 | $2.06 | -0.9% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*